Summary Nine primary pulmonary carcinomas, one metastatic carcinoma, and two malignant pleural mesotheliomas have been analysed for the expression at the mRNA level of metalloproteinases (MPs) and tissue inhibitors of MPs (TIMPs). In situ hybridisation showed TIMP-1 and TIMP-2 transcripts predominantly over tumour stroma and gelatinases evenly distributed over both stromal and tumour cells. While both TIMP-1 and TIMP-2 were expressed in non-neoplastic lungs (NNL) as well as in carcinomas, stromelysin 3 (ST3), 92 kDa gelatinase and interstitial collagenase were expressed only by carcinomas. Expression of these MPs by carcinomas was independent of histologic type and such tumour features as fibrosis or necrosis. The consistent expression of ST3 by all of the carcinomas examined and absence of its expression in NNL indicates that ST3 production is likely associated with the malignant phenotype. However, since 92 kDa gelatinase and interstitial collagenase transcripts were found in some but not all tumour samples, their expression is not a uniform feature of pulmonary carcinomas. The possible prognostic significance of the expression of the latter two enzymes by carcinomas remains to be established.
Turnover of the extracellular matrix (ECM) takes place relatively slowly in mature tissues but the pace is greatly accelerated during the tissue remodelling that accompanies processes such as inflammation or malignancy. Matrix degradation is a tightly regulated process in which secreted enzymes of the metalloproteinase (MP) family play key roles (Murphy & Reynolds, 1985; Matrisian, 1991; Birkedal-Hansen et al., 1992) . MPs are Zn-dependent proteinases which include interstitial (or specific) collagenase, gelatinases (type IV collagenases), stromelysins (or proteoglycanases) and PUMP-1 (originally, putative metalloproteinase-1) (Whitham et al., 1986; Collier et al., 1988; Muller et al., 1988; Quantin et al., 1989; Wilhelm et al., 1989; Brown et al., 1990) . These enzymes display characteristic substrate specificities and in combination they are able to destroy all the constituent proteins of the ECM (Murphy & Reynolds, 1985; Collier et al., 1988; Matrisian, 1991) . The function of MPs is regulated at several levels. Transcription of some members of the family is strongly influenced by cytokines and inflammatory mediators (Saklatvala, 1985; Stetler-Stevenson et al., 1990; Circola et al., 1991) . Moreover, MPs are released from cells as inactive proenzymes that have to be activated by proteolysis, often by serine proteinases that function in a 'cascade' mechanism (Murphy & Reynolds, 1985; Matrisian, 1991; Birkedal-Hansen et al., 1992) . When activated their enzymatic activity is controlled by specific tissue inhibitors (TIMPs). Two TIMPs (TIMP-1 and TIMP-2) have been described both of which have similar activities against the major MPs (Murphy & Reynolds, 1985; Goldberg et al., 1989; Stetler-Stevenson et al., 1989; Boone et al., 1990; Matrisian, 1991; Birkedal-Hansen et al., 1992) . Considerable evidence supports the notion that the balance between the levels of extracellular MPs and TIMPs is the primary determinant of the rate of ECM turnover.
The purpose of this study was to investigate the patterns of expression of major MPs and TIMPs in primary lung carcinomas. Correlation of such results with data obtained from non-neoplastic lung tissue (NNL) will identify those MPs which may play significant roles in the pathophysiology of pulmonary carcinomas. It will also help to focus future research on possible associations between these ECM-regulating functions and other factors such as cytokines, the interplay between which may have important consequences for the processes of invasion and metastasis.
Materials and methods

Source of tissue
The tissue was obtained from 10 lungs resected for carcinomas (nine cases of primary carcinomas, one of metastatic colonic carcinoma) and two cases of malignant pleural mesotheliomas. These originated from five women and seven men. Lung resections were received fresh in the Department of Pathology where appropriate sections were taken for RNA extraction, quick frozen in liquid nitrogen and then stored at -70°C. In each case tissue was taken from two aspects of the tumour, one underneath the pleura and one from the opposite aspect (medial). Samples of non-neoplastic lung were taken from sites away from the tumour as controls. The sections of areas taken as controls were examined histologically in order to eliminate tissue which would contain endogenous pneumonia or fibrosis. An additional section of tumour was frozen in liquid nitrogen in OCT-medium and stored at -70'C for subsequent in situ hybridisation studies.
DNA probes
Full-length human TIMP-1 and human interstitial collagenase cDNA probes were described previously (Edwards et al., 1987; Kossakowska et al., 1991) . The TIMP-2 full length human gene was isolated by polymerase chain reaction (PCR) amplification from cDNA prepared from human MRC5 fetal lung fibroblasts. The PCR product was generated using oligonucleotides that introduced Sma I and Stu I sites 5' and 3' of the coding region, giving rise to a 680 bp fragment containing the entire human TIMP-2 coding region (Boone et al., 1990) . After digestion with Sma I and Stu I, the PCR product was cloned into EcoRV cut pBluescriptIl KS and its identity was confirmed by DNA sequence analysis.
The 72 kDa type IV collagenase was a 210 bp fragment of C-terminal and 3'-non-coding sequences kindly provided by Dr A. Docherty (Celltech, UK), and was also described previously (Kossakowska et al., 1991 collagenase probe was a donation from Dr G. Goldberg, Division of Dermatology, Washington University School of Medicine, St. Louis, Missouri, USA (Wilhelm et al., 1989) . The stromelysin-3 cDNA probe was a generous gift from Dr P. Chambon, Laboratoire de Genetique Moleculare des Eukaryotes du CNRS, Strasbourg Cedex, France (Basset et al., 1990) , and PUMP-1 was obtained from Dr L. Matrisian, Vanderbilt University Medical School, Nashville, Tennesse (Matrisian, 1991) .
RNA isolation and northern blot analysis Total cellular RNA was extracted from lung tissue homogenised in guanidinium isothiocyanate and centrifuged through cesium chloride gradients as previously described (Kossakowska et al., 1991) . Total cellular RNA (10 g) from each case was electrophoresed in formaldehyde containing 1.1% agarose gels, transferred to HYBOND-N membranes (Amersham) in 20 x SSC buffer and fixed by baking at 80°C for 2 h. The blots were probed with nick-translated 32P-labelled DNA probes (specific activity> 108 c.p.m. fig-' ) and autoradiographed using Kodak XAR-5 film (Eastman Kodak, Rochester, NY). Subsequently, blots were reprobed with a murine 18S rRNA probe or stained with methylene blue to confirm equivalence of loading. Comparisons between different blots were made possible by the inclusion of two common samples on each.
RNA probe preparation and in situ hybridisation Sense and anti-sense 35S-RNA probes were prepared from human TIMP-1, TIMP-2, 72 kDa gelatinase and 92 kDa gelatinase cDNAs cloned in either pBluescript KS-(Stratagene) or pGEM2 (Promega) vectors. Details of the TIMP-l probes have been described previously (Kossakowska et al., 1991) . For TIMP-2 in pBluescript KS-, sense probes were generated by T3 polymerase following digestion with EcoRI, and anti-sense probes were made by T7 polymerase after HindlII digestion of template. The sense and anti-sense 72kDa gelatinase probes were produced from template digested with BamHI and XbaI, using T7 and T3 polymerases, respectively. For in situ studies a fragment of 92 kDa gelatinase from the 5' end of the cDNA to a BamHI site at nucleotide 390 (Wilhelm et al., 1989) was subcloned into pBluescript KS-, and sense and anti-sense probes were made from NotI and EcoRV restricted templates, with T3 and T7 polymerases, respectively.
For in situ hybridisation 2-3tim thick cryostat sections were placed on glass slides coated with 2% aminopropyltriethoxysilane and fixed with 4% para-formaldehyde. After rehydration the sections were washed in 4 x SSC prior to acetylation and pre-hybridisation in 4 x SSPE (Sambrook et al., 1989) , 1 x Denhardt's solution, and 50% deionised formamide, 20mM dithiothreitol and 40 lgml-l E. coli tRNA at 50°C for 3 h. The labelled riboprobes were diluted in the prehybridisation mixture at a concentration of 3-5 ng of RNA (1-2 x 10 c.p.m.) per 20 lI aliquot per slide. The hybridisation was carried out at 50°C for 18 h. The slides were then processed through the following stringency washes: 2 x SSC at room temperature, 2 x SSC at 50°C, RNase A (4 gg ml -) treatment for 30 min at 37°C, 2 x SSC at 50°C. Figure 1 Stromelysin-3, TIMP-1, and TIMP-2 expression in lung carcinomas, adjacent non-neoplastic lung tissue, and mesothelioma. All lanes contained total cellular RNA (10 pg) derived from the following cases (as in Table I ): lanes I to 5, case 9; lane 6, mesothelioma; lanes 7 and 8, case 5; lane 9 and 10, case 8, lane I1, case 2; lanes 12 and 13, case 1. The upper panel represents the blot hybridised with 32P nick-translated stromelysin-3 DNA probe, the middle panels show the same blot rehybridised with TIMP-1 and TIMP-2 DNA probes and the lowest panel shows loading control hybridisation with 18S rRNA. These autoradiographs were obtained after 48 h exposure at -70C with an intensifying screen. The blot hybridised with 18S rRNA was exposed for 24 h at room temperature without the intensifying screen. Tissue origins are indicated as: TUP, tumour-pleural; TUM, tumourmedial; L, non-neoplastic lung; PL, uninvolved pleura; M, mesothelioma.
exposure at 4°C the slides were developed in Dektol (Eastman Kodak Co.) and counterstained with haematoxylin and eosin.
Results
Northern blot analysis was carried out to establish the expression patterns of the 72 kDa and 92 kDa gelatinases, interstitial collagenase, stromelysin 3, PUMP-1, and TIMPs-I and -2 in the nine primary lung carcinomas, one metastatic colonic carcinoma to lung, two mesotheliomas, and NNL (including uninvolved pleura). The NNL included seven cases of morphologically normal lung adjacent to carcinomas. Representative data are shown in Figures 1 and 2 , and the results are summarised in Table I The RNAs coding for TIMP-1 and TIMP-2, 72 kDa gelatinase and PUMP-1 were present in malignant samples as well as NNL. Our experiences with many Northern blots suggest that TIMP-1 is the most highly expressed of all of the genes that we have analysed but its expression is variable and generally higher in tumour vs non-neoplastic lung samples ( Figure 1) . As reported previously, we observed two major classes of TIMP-2 transcripts of 3.5 kb and 1.0 kb sizes, with an additional minor 2.5 kb form in most tissues (Figure 1 ) (Leco et al., 1992; Stetler-Stevenson et al., 1990) . In almost all cases the 3.5 kb species was the most abundant with the 1.0 kb form being barely visible for some tumour RNAs, as has been seen previously in RNAs extracted from colorectal tumours (Stetler-Stevenson et al., 1990) .
Two additional points are apparent from inspection of the data presented in Table I and Figures 1 and 2 . Firstly, both malignant pleural mesotheliomas studied showed no expression of 72 kDa and 92 kDa gelatinases and PUMP-1, whereas the majority of carcinomas expressed these genes. Secondly, all analysed adenocarcinomas exhibited some degree of fibrosis, while necrosis was more prominent in (Basset et al., 1990 Both TIMP genes and PUMP-1 were expressed in all normal and malignant tissue samples analysed. The TIMP-2 signal, which is largely attributable to the 3.5 kb RNA, was relatively constant in both neoplastic and non-neoplastic lung samples. In agreement with previous studies (Stetler-Stevenson et al., 1990; Kossakowska et al., 1991) , our data demonstrate that TIMP-1 is expressed predominantly by host stromal cells with transcript levels being elevated in some of the tumour samples, possibly indicating the influence of tumour-derived diffusible factors. Our data are the first to demonstrate spatially-restricted TIMP-2 expression to stromal elements in tumour. These findings support the idea that the TIMPs may play a role in human neoplasia due to their abilities to inhibit the active forms of MPs (DeClerck et al., 1991) .
In summary, our conclusions are: 1. Stromelysin 3 is consistently found to be expressed in carcinomas but not in non-neoplastic lung tissue.
2. 92 kDa gelatinase and interstitial collagenase transcripts are also absent from NNL and are present in some but not all carcinomas. 3. Transcripts for 92 kDa and 72 kDa gelatinases are present in both tumour and stromal cells, whereas TIMP-1 and TIMP-2 RNAs are principally localised to host stroma.
This study extends to pulmonary carcinoma the association between expression of ST3 and malignancy that had been made from investigations of breast carcinoma (Basset et al., 1990) . It also indicates that 92 kDa gelatinase and interstitial collagenase may play important roles in the biology of certain carcinomas. More cases will be anlaysed and followed for an adequate period of time in order to establish any prognostic significance of expression of these two proteinases.
